2-溴-3,4-二氟苯胺 | 1092349-87-5

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯胺系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-3,4-二氟苯胺
• 英文名称: 2-bromo-3,4-difluoroaniline
• CAS: 1092349-87-5
• 化学式: C₆H₄BrF₂N
• 分子量: 208.005
• InChiKey: ZGZURPPCPVPDMX-UHFFFAOYSA-N

物化性质

• 沸点：
  236.4±35.0℃ (760 Torr)
• 密度：
  1.788±0.06 g/cm3 (20 ºC 760 Torr)
• 闪点：
  96.8±25.9℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  6.1
• 海关编码：
  2921420090
• 危险性防范说明：
  P261,P280,P305+P351+P338,P304+P340,P405,P501
• 危险性描述：
  H302,H312,H315,H319,H332,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-3,4-difluoroaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H312: Harmful in contact with skin
H332: Harmful if inhaled
Causes skin irritation
H315:
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-3,4-difluoroaniline
CAS number: 1092349-87-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H4BrF2N
Molecular weight: 208

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (2-Bromo-3,4-difluoroaniline)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-3,4-二氟苯胺 在 盐酸 、 硫酸 、 盐酸羟胺 、 四丁基溴化铵 、 potassium acetate 、 palladium diacetate 、 sodium hydride 、 对甲苯磺酸 、 sodium sulfate 作用下， 以 四氢呋喃 、 水 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 25.5h， 生成 1,2-difluoro-4H-pyrrolo[3,2,1-ij]thieno[3,2-c]quinoline-4,5(7H)-dione
  参考文献：
  名称：

  通过分子内直接丙烯酸化共轭噻吩融合的伊斯丁染料

  摘要：

  我们报告的创新，平面，π-共轭化合物的设计，合成和属性，其中噻吩环与天然染料isatin的骨架融合。利用分子内直接芳基化反应作为关键步骤，可以高收率实现合成，从而使整个过程具有潜在的可扩展性。对于在芳族环上带有氟取代基的靛红也已经证明了合成顺序。NMR和X射线研究表明，在融合，共面和共轭部分之间发生了串扰，使这些新型染料具有供体-受体特性。循环伏安法和UV-vis研究证实了新化合物的HOMO-LUMO水平和能隙非常有趣。

  DOI：

  10.1021/acs.joc.6b01922

文献信息

• [EN] PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDINONE ET DE PYRIMIDINONE COMME INHIBITEURS DU FACTEUR XIA
  申请人：ONO PHARMACEUTICAL CO

  公开号：WO2013093484A1

  公开（公告）日：2013-06-27

  The present invention provides compounds of the general formula (I), their salts and N- oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.

  本发明提供了一般式(I)的化合物，它们的盐和N-氧化物，以及它们的溶剂合物和前药（其中字符如描述中所定义）。一般式(I)的化合物是因子XIa的抑制剂，因此它们在预防和/或治疗血栓栓塞疾病方面是有用的。
• HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
  申请人：Enanta Pharmaceuticals, Inc.

  公开号：US20190002479A1

  公开（公告）日：2019-01-03

  The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明公开了式（I）的化合物，或其药学上可接受的盐、酯或前药：这些化合物抑制呼吸道合胞病毒（RSV）。本发明还涉及包含上述化合物的药物组合物，用于治疗患有RSV感染的受试者。该发明还涉及通过给予包含本发明化合物的药物组合物来治疗受试者的RSV感染的方法。
• [EN] FACTOR Xla INHIBITORS<br/>[FR] INHIBITEURS DU FACTEURS XIA
  申请人：MERCK SHARP & DOHME

  公开号：WO2020086416A1

  公开（公告）日：2020-04-30

  The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

  本发明提供了一种化合物的化学式(I)以及包含一种或多种所述化合物的药物组合物，以及使用所述化合物用于治疗或预防血栓、栓塞、高凝血性或纤维化变化的方法。这些化合物是选择性因子XIa抑制剂或因子XIa和血浆激肽原的双重抑制剂。
• 吡啶并嘧啶酮类化合物及其应用
  申请人：广州必贝特医药技术有限公司

  公开号：CN112159405A

  公开（公告）日：2021-01-01

  本发明提供了具有通式(II)所示结构的吡啶并嘧啶酮类化合物及其应用。研究证明，本发明提供的化合物可以有效抑制KRAS G12C突变。KRAS突变在肿瘤中占比很大，且目前没有获得批准药物对其进行治疗，本发明提供的化合物有潜力成为携带KRAS G12C突变的恶性肿瘤(尤其是非小细胞肺癌(NSCLC)和直结肠癌)的治疗药物，有较大的应用价值。
• One-Pot Synthesis of Indole-3-acetic Acid Derivatives through the Cascade Tsuji–Trost Reaction and Heck Coupling
  作者：Dongsheng Chen、Yuanyuan Chen、Zhilong Ma、Lei Zou、Jianqi Li、Yu Liu

  DOI：10.1021/acs.joc.8b01056

  日期：2018.6.15

  palladium-mediated cascade Tsuji–Trost reaction/Heck coupling of N-Ts o-bromoanilines with 4-acetoxy-2-butenonic acid derivatives using a Pd(OAc)2/P(o-tol)3/DIPEA system is described for a straightforward synthesis of indole-3-acetic acid derivatives. This methodology was successfully applied to synthesize various substituted indole/azaindole-3-acetic acid derivatives and Almotriptan, which is a drug for the acute

  描述了实用的钯介导的级联Tsuji-Trost反应/ N-Ts邻溴苯胺与4-乙酰氧基-2-丁烯酸衍生物的Heck偶联，使用Pd（OAc）2 / P（o- tol）3 / DIPEA系统用于吲哚-3-乙酸衍生物的直接合成。该方法成功地用于合成各种取代的吲哚/氮杂吲哚-3-乙酸衍生物和阿莫曲普坦，阿莫曲普坦是用于治疗偏头痛的药物。此外，已经提出了合理的环化机制。